A Fresh Take on GLP-1 Support
US$ 25.94
glp-1 vs metformin RA initiation versus and risk of cardiomyopathy in patients with cancer and diabetes treated with chemotherapy, radiation, or immunotherapy: a target trial emulation Comparing Glucagon‐like peptide‐1 receptor agonists
Description
And the substitution does not stop there
Duffy, A
OW in the abdomen or thigh
J Clin Invest 113, 635645 (2004)
FR reports equity from Carta Healthcare and HealthPals, and consulting fees from HealthPals, Novartis, NovoNordisk, Esperion Therapeutics, Movano Health, Kento Health, Inclusive Health, Edwards, Arrowhead Pharmaceuticals, and HeartFlow outside the submitted work
This is primarily because incretin mimetics cater to chronic, complex conditions like T2DM that often require specialist involvement and management
